一亩田美股招股说明书(2026-05-20版)

Prospectus Supplement No.5(To Prospectus datedMarch 9, 2026) Up to 42,307,692 American Depositary Shares Representing up to 1,057,692,300 Class A Ordinary Shares This prospectus supplement is being filed to update and supplement the information contained in the prospectus dated March9, 2026 (as supplemented or amended from time to time, the “Prospectus”), which forms a part of our Registration Statement onFormF-1 (Registration No.333-293952),as amended and supplemented. The Prospectus relates to the resale, from time to time, up to42,307,692 American depositary shares (the “ADSs”), representing 1,057,692,300 Class A ordinary shares, par value of US$0.00001per share, of Yimutian Inc. (the “Company”) issuable upon the conversion or otherwise pursuant to the terms of up to an aggregateprincipal amount of US$10,000,000 of senior convertible promissory note (the “Notes”) issued or issuable to the selling shareholdernamed in the Prospectus (the “Selling Shareholder”), pursuant to the terms of that certain securities purchase agreement, dated as ofDecember 8, 2025 (the “Securities Purchase Agreement”), by and between the Company and the Selling Shareholder, from time totime and upon the terms and conditions thereof (assuming full conversion of the Notes and interest payments made in ADSs at a priceof US$0.26 per share, the current floor price of the Initial Note). Each ADS represents 375 Class A ordinary shares. This prospectus supplement updates and supplements the information in the Prospectus and is not complete without, and maynot be delivered or utilized except in combination with, the Prospectus, including any amendments or supplements thereto. Thisprospectus supplement should be read in conjunction with the Prospectus and if there is any inconsistency between the information inthe Prospectus and this prospectus supplement, you should rely on the information in this prospectus supplement. Our ADSs are listed on the Nasdaq Global Market (“Nasdaq”) under the trading symbol “YMT”. On May 19, 2026, theclosing price for our ADSs on Nasdaq was US$2.01 per ADS. We may further amend or supplement the Prospectus and this prospectus supplement from time to time by filing amendmentsor supplements as required. You should read the entire Prospectus, this prospectus supplement and any amendments or supplementscarefully before you make your investment decision. Investing in our securities involves a high degree of risk. See “Risk Factors” beginning on page28 of the Prospectusfor a discussion of information that should be considered in connection with an investment in our securities. Neither the U.S. Securities and Exchange Commission nor any other regulatory body has approved or disapproved ofthese securities or determined if thisprospectus supplementor the Prospectus is truthful or complete. Any representation tothe contrary is a criminal offense. The date of this prospectus supplement is May 20, 2026. Yimutian Inc. Announces Receipt of Nasdaq Notification Regarding Market Value of Listed Securities Requirement andNasdaq Delisting Notice Subject to Hearing Request On May 19, 2026, the Company announced that it received two written notifications from the Listing QualificationsDepartment of The Nasdaq Stock Market LLC (“Nasdaq”) on May 13, 2026, the details of which are described below. On May 13, 2026, the Company received a written notification (the “MVLS Deficiency Notice”) from Nasdaq onMay 13,2026, notifying the Company that it is currently not in compliance with Nasdaq Listing Rule 5450(b)(2)(A), which requires theCompany to maintain a minimum market value of listed securities (“MVLS”) of US$50,000,000 for continued listing on the NasdaqGlobal Market (the “MVLS Requirement”). Based on the Company’s MVLS for the 30 consecutive business days from March 25,2026 to May 6, 2026, the Company no longer meets this requirement. The MVLS Deficiency Notice is only a notification ofdeficiency and has no immediate effect on the listing of the Company’s American Depositary Shares (“ADS”). The Company’s ADSswill continue to trade on The Nasdaq Global Market at this time. The Company’s receipt of the MVLS Deficiency Notice does notimpact the Company’s business, operations or reporting requirements with theU.S. Securities and Exchange Commission (the “SEC”). Pursuant to Nasdaq Listing Rule 5810(c)(3)(C), the Company has a compliance period of 180 calendar days, or untilNovember 9, 2026 (the “Compliance Period”), to regain compliance with Nasdaq’s MVLS Requirement. If at any time during theCompliance Period, the Company’s MVLS closes at US$50,000,000 or more for a minimum of 10 consecutive business days, Nasdaqwill provide the Company a written confirmation of compliance and the matter will be closed. Additionally, on May 13, 2026, the Company also received a determination letter (the “Determination Letter”) from Nasdaq,notifying the Company that, due to the its failure to regain compliance with the minimum market value of